- Home
- About us
- News
- Events
- EXPORT Export
-
BUY
Buy
Buy
- INVEST Invest
- COUNTRY BRAND Country Brand
-
INFORMATION CENTER
Information center
InformationCenterInformationCenterReports Country reports Department reports Foreign trade reports Product-Destination worksheet Sectors reports Work documentsStatistical information Classification Uruguay XXI Exports Imports Innovative National Effort Macroeconomic Monitor Tools Buyers Exporters Investors
- Contact
-
Languages



Uruguay Best Practices in Pharma Supply Chain 2025
- AGENDA -
8:30 | Accreditations
9:00 - 9:15 Welcome & Introduction
9:15 - 9:30 PANEL I - Uruguay Pharma Hub: Value Proposition
9:30 - 10:15 PANEL II - Pharma Hub & Regulatory: Safety and Efficiency
10:15 - 11:00 | Coffee Break
11:00 - 11:30 Talk: Pharmaceutical Supply Chain: Disruptions, Lessons, and Best Practices by Marco Guimaraens
11:55 - 12:40 PANEL III - Female Leadership in Pharma Supply Chain
12:40 | Lunch
14:10 - 14:55 PANEL IV - Technology and Innovation at the Service of the Pharma Supply Chain
14:55 - 15:40 PANEL V - Sustainability and Impact
15:40 - 16:25 PANEL VI - Talent for the Future of Pharma Supply Chain
16:25 - 16:55 Talk: "The Science of Enduring: An Empirical Formula for Chaos. When Internal Chemistry Breaks Down, the Soul’s Chemistry Holds" by Javier Artigas Herrera
16:55 | Closing Cocktail
____________________________________
Become an official sponsor in a unique space that connects the key players in the sector. Access our commercial proposal here, featuring various plans and benefits designed to maximize your visibility and recognition.
Get in touch with us
Event declared of nacional interest
_______________________________________
SPONSORS:
PLATINUM
____________________________
GOLD
____________________________
SILVER
____________________________
Previous editions
Best Practices in Pharma Supply Chain 2024
Best Practices in Pharma Supply Chain 2023
2020 - 2021 Webinar series
Best Practices in Pharma Supply Chain 2019
Organized by
Uruguay XXI works to promote the internationalization of the Life Sciences sector as a priority area, developing strategies focused on attracting investment, promoting exports and innovative aftercare policies.